EDITORIAL 020 7501 6745 Editor-in-chief Chris Bennett 020 7501 6660 chris.bennett@markallengroup.com Editor Simon Jones 020 7501 6667 simon.jones@markallengroup.com Deputy editor Mike Hale 020 7501 6670 mike.hale@markallengroup.com Clinical editor (Optometr y) Dr Manbir Nagra manbir.nagra@markallengroup.com Clinical editor (Dispensing) Tina Arbon Black tina.arbonblack@markallengroup.com Content editor Andrew McCarthy-McClean 020 7501 6788 andrew.mcclean@markallengroup.com Acting online editor Emma White 020 7501 6663 emma.white@markallengroup.com Production editor Gar y O’Connell 020 7501 6706 gar y.oconnell@markallengroup.com Ar t editor Sara Challinor 020 7501 6666 sara.challinor@markallengroup.com ADVERTISING & SPONSORSHIP Associate publisher Darren Ward 020 7501 6668 darren.ward@markallengroup.com Key account manager Joseph Lever 020 7501 6708 joseph.lever@markallengroup.com RECRUITMENT & CLASSIFIED Recruitment solutions manager Daniel Doherty 020 7501 6686 daniel.doherty@markallengroup.com Managing director Anthony Kerr 020 7501 6726 anthony.kerr@markallengroup.com Group production manager Kyri Apostolou 020 7501 6779 kyri.apostolou@markallengroup.com Production director Richard Hamshere Chief executive officer Ben Allen Chairman Mark Allen EDITORIAL ADVISORY BOARD Will Ayliffe PhD FRCS FRCOphth DO; Sally Bates FBDO; Dr Frank Eperjesi PhD BSc MCOptom FAAO; Professor Bernard Gilmartin PhD FCOptom FAAO; Graham Hutchison MBA; Professor Mo Jalie SMSA FBDO FCGI MIMgt; Dr Lyndon Jones PhD FCOptom DCLP DOrth FAAO; Geoff Roberson BSc FCOptom; Dr Steve Taylor PhD MSc FCOptom; Graeme Young MPhil FCOptom DCLP FAAO SUBSCRIPTIONS 0800 137201 Subscribe or renew 01722 716997 subscriptions@markallengroup.com BACK ISSUES 01722 716997 REPRINTS 020 7501 6790 ISSN 0030.3968
Par t of www.markallengroup.com
Optician is published ever y Friday © 2024 MA Healthcare Ltd St Judes Church, Dulwich Road, London SE24 0PB. Telephone 020 7738 5454 Website: www.opticianonline.net ISSN 0030.3968 Printed in Britain by Pensord Press, Tram Road, Pontllanfraith, Gwent, NP12 2YA Please read our privacy policy at privacypolicy.markallengroup.com. This will explain how we process, use and safeguard your data
4 OPTICIAN 9 Februar y 2024
facebook.com/opticianonline
7 DAYS
To read the full stories and keep up to date on the latest news and views visit opticianonline.net
GOC welcomes committee members
Contact lens optician Lisa Cole and dispensing optician Ashley Francis joined the GOC Committee on January 15 to help ‘protect the public’ at the fitness to practise investigations stage.
Cole and Francis would consider allegations that a registrant may not be fit to practise, where case examiners cannot agree, and review registrants’ health or performance. Mecs-accredited Cole currently supervised and assessed undergraduate optometry students at the University of the West of England and has over 33 years’ optical sector experience, including several in practice management.
Francis worked across North Wales and Northwest England, beginning his career as an optical assistant, later training in an optical lab as a glazing technician and then becoming a trainer in the same practice.
Leightons and Clapham Optical merge Leightons Opticians and Hearing Care and Clapham Optical have merged to offer eye and hearing care services to Totton and the surrounding areas.
The Clapham and Leightons partnership encompassed Commercial Road’s newly named Clapham & Leightons: Optical Centre and Clapham & Leightons:
Nick Clapham and Ryan Leighton
Hearing Centre on Water Lane.
Owners Nick Clapham and Ryan Leighton are the third-generation ‘caretakers’ of the companies built by their grandfathers, priding themselves on ‘high quality care and exquisite products’.
‘It is an honour to be joining together with another independently run family business, with whom we share not just similar values, but a similar history too,’ said Leighton.
Marsha de Cordova timely specialist care that’s also closer to their home.’
MP champions optoms at AOP event MP for Battersea Marsha de Cordova discussed the importance of primary eye care services at a practice visit and roundtable event on January 26 organised by the Association of Optometrists (AOP).
Optometrist Karen Lockyer hosted the event at her practice Karen Lockyer Optometrists in Battersea, which was attended by independent and multiple practices, Moorfields Eye Hospital and the Local Optical Committee.
The roundtable discussion, facilitated by AOP clinical and professional director Dr Peter Hampson, explored how services vary depending on locality and how extended eye care could be provided in the community.
Attendees also addressed the need for improved IT connectivity between optometry and hospital teams and reiterated the need for a national eye care strategy.
De Cordova, also chair of the All Party Parliamentary Group on Eye Health and Visual Impairment, said: ‘With hospital eye services across the nation facing increasing strain, sadly it is the patients that suffer the consequences, waiting inexcusable amounts of time for diagnosis and treatment.
‘If commissioned equitably, extended eye care services would enable more patients to access
Red light rebuttal Research suggesting repeated lowlevel red-light (RLRL) for treatment of myopia can cause photochemical and thermal damage (News 02.02.24) has been refuted by Eyerising International, which produces a RLRL device cited in the research.
A company statement said its device was referred to in a ‘negative and inaccurate manner’ several times within the research, which was published in Ophthalmic & Physiological Optics Journal.
Eyerising International said the device was not tested during the research, but was still compared to other RLRL devices, which were measured in the researchers’ laboratory.
A company statement said: ‘The Eyerising device has undergone 10 clinical trials and four real world studies, covering 1,785 patients, with a cumulative clinical trial use of nine-and-a-quarter years with zero significant adverse events recorded.
‘The device has been used to treat more than 160,000 patients in the real world over the past eight years, and there are currently more than 80,000 daily users. To date, there have only been five cases of significant adverse side effects reported; with no permanent damage recorded.’
Eyerising International confirmed Ophthalmic & Physiological opticianonline.net